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Introduction: Diabetes is one of the major burdens of non-communicable disease causing morbidity and 
mortality. Glycated hemoglobin (HbA1c) has been used as a tool to monitor glycemic control in patients with 
type 2 diabetes mellitus and elevated HbA1c value is considered an independent risk factor for dyslipidemia. 
Methods: A total of 120 patients with type 2 diabetes mellitus were enrolled in this cross-sectional study. 
Means with standard deviation were used for age, height, weight and fasting blood sugar and Pearson 
correlation test was applied to identify correlation between Glycated hemoglobin (HbA1c) and lipid profile. 
Comparison of means was done by Student 't' test in parametric data within the two groups. P value less than 
0.05 was considered significant. Results: The mean HbA1c of male and female patients were 8.35±1.77 and 
8.65±1.95 respectively. Among patients with good glycemic control, mean total cholesterol and mean high 
density lipoprotein were higher than poor glycemic control patients. Patients with poor glycemic control 
had higher mean triglyceride  and low density lipoprotein  than good glycemic control patients. Correlation 
coefficient for various components of lipid profile and HbA1c were: total cholesterol (r=0.189, p=0.038, 
n=120), triglyceride (r=0.418, p<0.01, n=120), low density lipoprotein (r=0.673,p<0.01,n=120) and high 
density lipoprotein ( r=-0.683,p<0.01, n=120). Conclusion: There was a significant moderate correlation 
between HbA1c and lipid profile. Lipid profile values were significantly higher in poor glycemic control than 
good glycemic control patients. Hence, HbA1c can be considered as a surrogate marker for dyslipidemia in 
type 2 DM patients.
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INTRODUCTION:
 Diabetes Mellitus (DM) is an endocrine 
disorder with high blood sugar level with 
disturbances of carbohydrate, lipid and protein 
metabolism resulting from variable degree of insulin 
resistance and deficiency or both.[1] Abnormalities 
of lipid profiles in diabetic patients often termed 
“diabetic dyslipidemia”, is characterized by high 
total cholesterol (TC), high triglycerides (TG), 
low high-density lipoprotein cholesterol (HDL-C), 
increased levels of low density lipoprotein (LDL) 
particles and increased levels of very low density 
lipoprotein choleserol (VLDL-C).[2]
 Glycated hemoglobin (HbA1c) shows the 
average plasma glucose over previous eight to 
twelve weeks and has been used as a tool to monitor 
glycemic control in patients with type 2 diabetes 
mellitus. An HbA1c of ≥6.5% is recommended by 
American Diabetic Association as the cut-off point 
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for diagnosis of diabetes mellitus.[3]
 Elevated HbA1c is an independent risk factor 
for dyslipidemia and coronary artery disease. It has 
also been seen that 18% Cardiovascular Disease 
(CVD) risk increase with every 1% increase in value 
of HbA1c in diabetic.[4] It has been suggested that 
a reduction of 0.2% in the value of HbA1c reduces 
mortality due to cardiovascular events by 10%. 
Studies done in the past have shown significant 
positive correlation of HbA1c with TC, LDL-C, and 
TG and significant negative correlation with HDL. 
The correlation between HbA1c and LDL and HDL 
were found to be strong as suggested by higher 
values of correlation coefficients 0.785 and -0.897 
respectively.[5]
 The aim of this study was to assess the 
relationship between HbA1c and serum lipid profile 
in type 2 Diabetic mellitus patients.
METHODS:
 This was a cross sectional study conducted 
at Lumbini Medical College and Teaching hospital, 
Palpa in the department of Internal medicine from 
May 2019 to November 2019. The study was 
approved by Institutional Review Committee (IRC) 
and written consent was obtained from all the 
patients. 
 All patients aged > 30 years with a known 
diagnosis or newly diagnosed with Type 2 Diabetes 
mellitus as per American Diabetic Association 
(ADA) criteria[3] were included in the study. 
Necessary demographic, clinical and laboratory 
parameters like age, sex, diabetes,  height, weight, 
blood sugar fasting and postprandial and various 
lipid profiles data were collected as in a preformed 
questionnaire through guided interview.
 Following participants were excluded from 
this study:
 Patients with known diagnosis of type-
1 Diabetes mellitus, hypothyroidism, chronic 
renal failure, nephrotic syndrome, familial 
hypercholesteremia, cholestatic jaundice, alcohol 
consumption, patient on lipid lowering drugs for 
some other indications, beta blockers or thiazide 
diuretics, paraneoplastic syndrome, anemic patients 
and obese patients. Samples were collected from 
patients attending outpatient department and 
stable indoor patients from department of Internal 
medicine. Cases were enrolled into study through 
purposive sampling.
Sample size calculation:
 From the previous study, correlation 
coefficient between HbA1c and lipid profiles (TC) 
was found to be 0.257(r).[4,5] With the help of this 
r value sample size was calculated using standard 
sample size calculation formula where alpha value 
0.05 and beta value 0.2 were taken. The standard 
normal deviate for α = Zα = 1.960, The standard 
normal deviate for β = Zβ = 0.842, C = 0.5 * 
ln[(1+r)/(1-r)] = 0.263 total sample size N= [(Zα + 
Zβ)/C]
2+3=117
Technique of sample collection: 
 Venous blood was collected into two vials, 
three milliliter blood in plain vial and two milliliter 
blood in potassium-EDTA vial. Fasting blood sugar 
was labeled as per fasting for eight hours and post 
prandial blood sugar was assessed two hours after 
food intake. Glucose oxidase-peroxidase (GOD-
POD) method was applied to measure fasting blood 
sugar and Nycocard Reader was used to estimate 
the glycated hemoglobin (HbA1c). Venous Blood 
sample was allowed to clot at room temperature in 
plain test tube and the serum was separated. Serum 
lipids (Triglyceride-TG, total Cholesterol-TC, 
and High-density lipoprotein cholesterol-HDL-C) 
measured directly and the value of Low-density 
lipoprotein cholesterol LDL-C was calculated using 
the Friedewald’s formula.[6] All these parameters 
were analyzed using a fully automated chemistry 
analyzer (Siemens AdviaCentuar 1800) and ready-
to-use reagent kits according to the manufacturer’s 
instructions (Siemens Diagnostics, Germany). 
Interpretation of lipid profile value was done as 
per national cholesterol education program-Adult 
treatment panel III (NCEP-ATPII). According to 
these guidelines’ recommendation normal, desirable, 
borderline and high-risk level of total cholesterol 
(TC) was defined as up to <200mg/dl, up to 200 
mg/dl, 200-239mg/dl and >240mg/dl respectively. 
Triglyceride (TG) value up to 149 mg/dl, 150-199 
mg/dl, 200-499 mg/dl and >500 mg/dl was defined 
as optimal normal, borderline, high and very high-
risk level TG respectively. Low density lipoprotein 
(LDL) level was defined optimal risk when <100 
mg/dl, near optimal 100-129 mg/dl, borderline high 
130-159 mg/dl, high 160-189 mg/dl and very high 
>190 mg/dl respectively and low risk HDL as >60 
mg/dl and high-risk level <40 mg/dl.[7] Optimal 
glycemic target was considered when FBS≤130mg/
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dl and PPBS≤180mg/dl and uncontrolled DM when 
it was greater than the optimal target value.Glycemic 
status was divided into two groups; Good Glycemic 
Control (GGC) if HbA1c<7% and Poor Glycemic 
Control (PGC) if HbA1c ≥ 7% as per ADA criteria.
[3]
 For collecting the sample, this study used the 
structure questionnaires covering the age, gender, 
height, weight, Body Mass Index (BMI), Fasting 
Blood Sugar (FBS), Postprandial (PP), and lipid 
profile of patients. With this evidence, we collected 
120 samples for this study. Data was analyzed with 
Statistical Package for Social Sciences (SPSSTM) 
software version 16.
 Normally distributed data were presented as 
mean and standard deviation. Pearson correlation 
test was done to identify the correlation between 
parametric data. Comparison of means was done by 
Student 't' test in parametric data with two groups. A 
p value less than 0.05 was considered significant.
RESULT:
 In our study, there were a total of 120 
patients. Age of the patients ranged from 30 to 90 
years and more than half were older than 60 years. 
Demographic parameters are shown in Table 1. 
There was no statistically significant difference  in 
age, height, weight, BMI, FBS, PPBS and HbA1c 
between the two genders.















































 A total of 96 (80%) patients had poor 
glycemic control (Table 2). 
Table 2. Frequency and mean of poor glycemic 
control patients in different gender.
N % Mean ± SD
HbA1c ≥ 7% 96 80 9.05 ± 1.65
HbA1c ≥ 7(male) 56 58.3 8.72 ± 1.66
HbA1c ≥ 7(female) 40 41.7 9.50 ± 1.53
 Among patients with uncontrolled DM, 
uncontrolled FBS was in 84 (70%) and uncontrolled 
PPBS in 69 (57.5%) patients. Their mean fasting 
and postprandial blood sugars were 170.87±39.42 
and 229.98±54.36 mg% respectively. Lipid profile 
levels in DM patients are described in Table 3.
Table 3. Lipid profile level in DM patients.
Choles-
terol























Total 120 120 120 120
 Among poor glycemic control patients, 
mean serum value of TG, LDL were statistically 
significantly higher and mean HDL was statistically 
significantly lower (Table 4).


























 Among various lipid profile, LDL cholesterol 
had moderate positive correlation and HDL 
cholesterol had moderate negative correlation with 
HBA1c values (Table 5).
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 Among various lipid profile in males, LDL 
cholesterol had moderate positive correlation 
whereas HDL cholesterol had moderated negative 
correlation.  Among females, LDL had high positive 
correlation and HDL had high negative correlation 
(Table 6). 
DISCUSSION:
 The percentage of diabetic patients has 
increased from 19.04% in 2002 to 25.9% in 2009 
in Nepal and is continuously growing ever since. A 
survey conducted in urban Nepal between 2001 and 
2002 showed that the ratio of Male: Female diabetics 
were 1.56:1.[8] Our study with type 2 DM revealed 
male to female ratio of 1.22:1
 The mean age of type 2 DM patients were 
57.77±16.13 and 61.89±15.46 years for male and 
female respectively. A study done by Hussain et 
al.[4] showed mean age of 51.71±11.70 years for 
male and 50.97±10.23 years for female.  Another 
study by Baranwal et al.[5] had nearly equal number 
of participants as ours and depicted mean age of male 
and female patients to be 52.7±11.9 and 51.84±12.1 
years respectively thus revealing that more elderly 
people with type 2 DM visited our hospital. Presence 
of various risk factors, change in life style, poor 
dietary intake, low physical exercise may be an 
explanation for these observed differences.[9,10,11] 
With this realization an appropriate intervention 
to avoid or minimize these unhealthy behaviors is 
essential and warranted. 
 Most of our patients had poor glycemic 
control (n=96, 80%). Majority of them were male 
patients and mean HbA1c among poor glycemic 
control patients was 9.05±1.65 (Table 2). This result 
was supported by various other studies but many 
of these studies showed disagreement with gender 
preponderance.[4,5,6]  
 More than 80% patients had high TC, TG 
with low HDL. Similarly, 44.2% had high LDL 
levels. These findings were also supported by some 
studies.[2,5] Meanwhile, we also found that there 
was an increase  mean  TG, LDL and decrease in 
HDL levels in poor glycemic control than good 
glycemic control patients. The study by Alzahrani et 
al. revealed partial agreement with our study where 
there was raised TG level in high HbA1c group.[12]
 We also studied the relationship of HbA1c 
with different lipid parameters. HbA1c showed 
significant positive relationship with TG (r=0.418, 
p<0.01) and LDL (r=0.64, p<0.01) and significant 
negative correlation with HDL (r=-0.683, p<0.01).
 We observed a positive significant 
correlation between HbA1c with TC, LDL, and TG 
and a significant negative correlation of HbA1c with 
HDL. These findings are valid with regards to the 
metabolic effect of hyperglycemia and deficiency of 
insulin on various lipid parameters. Various studies 
done by many  authors have mixed results of HbA1c 
with various lipids profile components.[2,4,5,6] 
These mixed findings were due to the differences 
in life style, genetic factors, behavioral and 
environmental factors.[14,15,16] Thus, measures 
to change unhealthy life style, promoting good and 
healthy diet, reducing body weight and performing 
regular physical exercise to improve or control 
diabetic dyslipidemia is mandatory.[17,18,19]
 The present study is not without limitations. 
The study was done on a small sample size. Impact 
Table 5. Correlations of HbA1c to lipid profile level.
Total Cholesterol TG LDL HDL
HbA1c Correlation (r) 0.189 0.418 0.673 -0.683
P-value 0.038 <0.01 <0.01 <0.01
Table 6. Lipid profiles correlation between male and female.
Variables Male P-Value Female P-Value
Correlation Correlation
TG 0.36 0.003 0.49 <0.001
LDL 0.64 <0.001 0.70 <0.001
HDL -0.58 <0.001 -0.83 <0.001
TC 0.24 0.051 0.13 0.34
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of patients’ dietary habits, lifestyle, regular physical 
activity/exercise, time and duration since diagnosis 
of DM were not determined in this study.
CONCLUSION:
 There was a significant moderate correlation 
between HbA1c and various components of lipid 
profile in type 2 DM patients. Lipid profile values 
were significantly higher in poor glycemic control 
and uncontrolled DM patients. Thus, HbA1c can be 
considered as a surrogate marker of dyslipidemia 
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